adj ep
debt total capit
ew report result beat consensu estim top-lin bottom-lin
behind anoth quarter robust tavr growth compani tavr perform
strong underli growth includ tavr growth despit
signific advers impact latter week march tmtt also
bright spot sale in-lin model despit march hit
viru guidanc front ew reset sale adj ep outlook year
account surpris view ew expect sale
underli growth adj ep compani
expect greatest impact sale follow gradual recoveri
larg resembl origin sale expect
recap close ew report result total sale
underli y/i street model closer adj gross
margin slightli better model adj oper
margin came well-ahead forecast adj ep better
consensu behind sale beat lower expect op ex spend
guidanc updat call ew provid updat
guidanc reflect pandem new guidanc includ sale
vs prior underli growth vs top-end
rang prior manag note expect greatest
impact sale follow gradual recoveri larg resembl
origin sale expect bottom-lin ew lower adj ep
ew note guidanc contempl second
larg outbreak later year ew guid sale manag
comment current outbreak improv stand
today ew would like come closer bottom rang
tavr global tavr sale underli easili eclips street
expect ew tavr growth strong across geographi led
 y/i growth ew said ww tavr growth earli march
consist underli encourag view
 strength driven patient surgic risk categori ou compani
post mid-teen tavr growth underli basi ew note saw better
expect growth europ prior slowdown japan post strong
growth didnt see much impact viru due ew
expect tavr growth underli vs prior
competit price pressur product delay advers clinic data litig
ew develop manufactur sell product treat structur heart diseas
provid critic care monitor market leader tavr valv
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
tmtt ew tmtt transcathet mitral transcathet tricuspid sale beat street
expect despit compani note signific pressur last
week quarter given somewhat disappoint stretch tmtt franchis
encourag see solid start year manag said compani saw
strong adopt pascal europ expect provid inform updat tmtt
therapi includ pascal cardioband evoqu upcom europcr meet late
may due disrupt ew lower tmtt sale outlook
surgic structur heart critic surgic structur heart ssh sale beat
consensu critic cc sale shi street like
area busi ew saw relat disrupt ssh expect
underli y/i growth full-year previous current
environ think patient steer physician toward transcathet base
procedur tavr vs open surgic procedur savr due shorter length stay fewer
resourc requir tavr critic compani saw decreas demand
enhanc surgic recoveri esr product hemospher partial off-set
increas need pressur monitor devic due compani expect flat
underli growth midpoint rang versu previou expect
growth
stock thought encourag strong start year compani market
lead tavr franchis continu momentum although challeng ew
everi med-tech compani believ ew well-posit head
trough think nearli tavr case deferred/postpon
reschedul subsequ quarter small portion patient may perish ew
strong balanc sheet manag team help compani success navig
unpreced time remain posit inclin share reiter ow rate
howev lower price target modestli reflect revis
forecast roll forward pt base adj ep
estim previou pt base adj ep
page
page
y/yactual-estimateadjust interest expens incom incom analysi gross gener develop oper growthnmnmnmnmsurg structur compani report piper sandler estim edward lifesci corpor ew
million
sale
revenu report
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
